Showing results (181-190 of 212) with videos related to

Sort By:
Pageof 22
Leukemia|March 27, 2026
Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemiaLoïc Vasseur, Matthieu Duchmann, Nicolas Duployez, et al.
British Journal of Haematology|April 19, 2022
A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher-Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutationsLionel Adès, Nicolas Duployez, Agnes Guerci-Bresler, et al.
Blood|April 20, 2022
Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO studyNicolas Duployez, Laëtitia Largeaud, Matthieu Duchmann, et al.
Blood|September 20, 2013
BCOR and BCORL1 mutations in myelodysplastic syndromes and related disordersFrederik Damm, Virginie Chesnais, Yasunobu Nagata, et al.
Haematologica|February 16, 2015
CD3-CD4+ lymphoid variant of hypereosinophilic syndrome: nodal and extranodal histopathological and immunophenotypic features of a peripheral indolent clonal T-cell lymphoproliferative disorderGuillaume Lefèvre, Marie-Christine Copin, Christophe Roumier, et al.
Haematologica|May 5, 2018
Natural history of GATA2 deficiency in a survey of 79 French and Belgian patientsJean Donadieu, Marie Lamant, Claire Fieschi, et al.
Rheumatology (Oxford, England)|February 17, 2022
Clonal haematopoiesis of indeterminate potential and cardiovascular events in systemic lupus erythematosus (HEMATOPLUS study)Clémence David, Nicolas Duployez, Philippine Eloy, et al.
Nature|December 8, 2016
A 17-gene stemness score for rapid determination of risk in acute leukaemiaStanley W K Ng, Amanda Mitchell, James A Kennedy, et al.
Haematologica|December 22, 2018
Poor prognosis of chromosome 7 clonal aberrations in Philadelphia-negative metaphases and relevance of potential underlying myelodysplastic features in chronic myeloid leukemiaAudrey Bidet, Stéphanie Dulucq, Thomas Smol, et al.
Blood Advances|March 21, 2024
Genomic profiling of mycosis fungoides identifies patients at high risk of disease progressionLéa Fléchon, Inès Arib, Ankit K Dutta, et al.
Pageof 22